Physician profile
Joseph Ibrahim
NPI 1225068281
$50,345.01
in general payments reported to CMS, 2019-2025
43 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,983 · 2020: $5,628 · 2021: $4,321 · 2022: $6,694 · 2023: $6,657 · 2024: $7,371 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $2,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,200.00 |
| Food and Beverage | $2,518.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kite Pharma, INC. | $43,550.00 | 2019-2025 | Tecartus, Yescarta |
| Collegium Pharmaceutical, INC. | $1,796.18 | 2019-2025 | Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $854.71 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $512.53 | 2021-2025 | Ztlido |
| Boston Scientific Corporation | $419.08 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $388.17 | 2019-2023 | Proclaim |
| Vertos Medical, INC. | $313.63 | 2019-2024 | Mild Device Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $184.30 | 2019-2020 | |
| Spr Therapeutics, INC | $180.17 | 2025 | Sprint Pns System |
| Shockwave Medical, INC | $163.34 | 2025 | |
| Azurity Pharmaceuticals, INC. | $159.33 | 2023-2025 | Horizant, Horizant |
| Horizon Therapeutics Plc | $153.28 | 2019-2022 | |
| Medtronic USA, INC. | $143.99 | 2019-2020 | |
| Heartflow, INC. | $132.90 | 2025 | |
| Medtronic, INC. | $114.08 | 2021-2024 | Intellis Adaptivestim |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.